Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 325.94% · OPTIONAL
· In Vitro & In Vivo Diagnostic Substances
RESEARCH SNAPSHOTInsight Molecular Diagnostics Inc.'s latest supported as-filed period reports revenue of $239,000; gross margin moved 188 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 325.94% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -3877.82% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -53.86% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 86.61% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 65.69% · CORE
Level · gp.fundamentals.operating_margin
Raw value -4770.71% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -26.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -188 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed -55.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
IMDX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001642380-26-000011SEC ↗8-KAug 10, 2026Period Aug 10, 20260001493152-26-036863SEC ↗4Jul 6, 2026Period Jul 1, 20260001493152-26-032235SEC ↗4Jul 6, 2026Period Jul 1, 20260001493152-26-032233SEC ↗4Jul 6, 2026Period Jul 1, 20260001493152-26-032231SEC ↗8-KJun 17, 2026Period Jun 11, 20260001493152-26-029078SEC ↗4Jun 15, 2026Period Jun 11, 20260001493152-26-028755SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 1, 2026Filed Jul 6, 2026 | SILVERMAN LOUDirector | Tax WithholdingDirect | 7,700 | $6 | $43,813 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 1876.99% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 276.57% · OPTIONAL
Inventory changed -70.1% from the comparable as-filed period.
Net income changed -15.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -15.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed -287071 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-028754